Why do some promising brain-stimulation devices fail the next steps of clinical development? (Q33519672)

27 July 2017

1 reference

title

Why do some promising brain-stimulation devices fail the next steps of clinical development? (English)

1 reference

Linamara Rizzo Battistella

27 July 2017

object named as

Linamara Battistella

series ordinal

3

0 references

Felipe Fregni

series ordinal

4

object named as

Felipe Fregni

1 reference

27 July 2017

Rodrigo C L Edelmuth

1

1 reference

PubMed ID

20021241

27 July 2017

Michael A Nitsche

series ordinal

2

1 reference

27 July 2017

1 January 2010

1 reference

Expert Review of Medical Devices

27 July 2017

1 reference

27 July 2017

7

1 reference

27 July 2017

1

1 reference

27 July 2017

67-97

1 reference

National Stroke Association guidelines for the management of transient ischemic attacks

27 July 2017

1 reference

Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (RTMS): comparisons with electroconvulsive shock (ECS).

21 January 2018

1 reference

Transcranial magnetic stimulation treatment for epilepsy: can it also improve depression and vice versa?

21 January 2018

1 reference

Noninvasive brain stimulation for Parkinson's disease and dystonia

21 January 2018

1 reference

TMS in cognitive plasticity and the potential for rehabilitation

21 January 2018

1 reference

Using non-invasive brain stimulation to augment motor training-induced plasticity

21 January 2018

1 reference

Recent advances in the treatment of chronic pain with non-invasive brain stimulation techniques

21 January 2018

1 reference

Technology insight: noninvasive brain stimulation in neurology-perspectives on the therapeutic potential of rTMS and tDCS.

21 January 2018

1 reference

[Transcranial magnetic stimulation in neuropsychology: new horizons for brain research].

21 January 2018

1 reference

Transcranial direct current stimulation: State of the art 2008

21 January 2018

1 reference

Neural correlates of transmeatal cochlear laser (TCL) stimulation in healthy human subjects

21 January 2018

1 reference

Effectiveness of transmeatal low power laser irradiation for chronic tinnitus

21 January 2018

1 reference

Transmeatal cochlear laser (TCL) treatment of cochlear dysfunction: A feasibility study for chronic tinnitus

21 January 2018

1 reference

Transmeatal low-level laser therapy for chronic tinnitus with cochlear dysfunction

21 January 2018

1 reference

Effects of transcranial micropolarization of the frontal cortex on the state of motor and cognitive functions in extrapyramidal pathology.

21 January 2018

1 reference

The effects of transcranial micropolarization on the severity of convulsive fits in children.

21 January 2018

1 reference

Transcranial micropolarization in the combined therapy of speech and general psychomotor retardation in children of late preschool age.

21 January 2018

1 reference

Pain reduction using transcranial electrostimulation: a double blind "active placebo" controlled trial

21 January 2018

1 reference

Efficiency of transcranial electrostimulation on anxiety and insomnia symptoms during a washout period in depressed patients. A double-blind study.

21 January 2018

1 reference

Favorable effect of transcranial electrostimulation on behavior disorders in elderly patients with dementia: a double-blind study.

21 January 2018

1 reference

Devices for noninvasive transcranial electrostimulation of the brain endorphinergic system: application for improvement of human psycho-physiological status

21 January 2018

1 reference

Immediate influence of transcranial electrostimulation on pain and beta-endorphin blood levels: an active placebo-controlled study

21 January 2018

1 reference

The amelioration of the suffering associated with spinal cord injury with subperception transcranial electrical stimulation

21 January 2018

1 reference

The effects of transcranial electrostimulation on the adaptive state.

21 January 2018

1 reference

Changes in spontaneous brain bioelectrical activity during transcranial electrical and electromagnetic stimulation.

21 January 2018

1 reference

Cranial electrotherapy stimulation as a treatment for anxiety in chemically dependent persons.

21 January 2018

1 reference

The use of cranial electrotherapy stimulation in the treatment of closed-head-injured patients.

21 January 2018

1 reference

Physiological and therapeutic effects of high frequency electrical pulses.

21 January 2018

1 reference

Evaluation of cranial electrostimulation therapy on short-term smoking cessation.

21 January 2018

1 reference

A study of the effects of cranial electrical stimulation on attention and concentration.

21 January 2018

1 reference

Quantitative analysis of the electroencephalogram during cranial electrotherapy stimulation.

21 January 2018

1 reference

Cranial electrostimulation (CES) in patients with probable Alzheimer's disease.

21 January 2018

1 reference

Effects of low-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease

21 January 2018

1 reference

High-frequency cranial electrostimulation (CES) in patients with probable Alzheimer's disease.

21 January 2018

1 reference

Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease: a pilot study.

21 January 2018

1 reference

Effects of cranial electrical stimulation on sleep disturbances, depressive symptoms, and caregiving appraisal in spousal caregivers of persons with Alzheimer's disease

21 January 2018

1 reference

Human sensitivity to weak magnetic fields

21 January 2018

1 reference

Differential ratings of pleasantness following right and left hemispheric application of low energy magnetic fields that stimulate long-term potentiation

21 January 2018

1 reference

Repeated verbal interruptions during exposure to complex transcerebral magnetic fields elicit irritability: implications for opiate effects

21 January 2018

1 reference

Resting EEG effects during exposure to a pulsed ELF magnetic field.

21 January 2018

1 reference

Increasing human brain excitability by transcranial high-frequency random noise stimulation

21 January 2018

1 reference

Therapeutic applications of ultrasound

21 January 2018

1 reference

Remote excitation of neuronal circuits using low-intensity, low-frequency ultrasound

21 January 2018

1 reference

A hemisphere array for non-invasive ultrasound brain therapy and surgery.

21 January 2018

1 reference

Demonstration of potential noninvasive ultrasound brain therapy through an intact skull.

21 January 2018

1 reference

Local frequency dependence in transcranial ultrasound transmission

21 January 2018

1 reference

A numerical study of transcranial focused ultrasound beam propagation at low frequency

21 January 2018

1 reference

Clinical applications of focused ultrasound-the brain.

21 January 2018

1 reference

Ultrasound, microbubbles and the blood-brain barrier

21 January 2018

1 reference

Escitalopram in specific phobia: results of a placebo-controlled pilot trial

21 January 2018

1 reference

A surveillance study of escitalopram treatment of depressed patients.

21 January 2018

1 reference

Escitalopram in the acute treatment of depressed patients aged 60 years or older

21 January 2018

1 reference

Escitalopram in the treatment of major depressive disorder in primary-care settings: an open-label trial

21 January 2018

1 reference

Impact of escitalopram treatment on Quality of Life Enjoyment and Satisfaction Questionnaire scores in major depressive disorder and generalized anxiety disorder

21 January 2018

1 reference

Escitalopram administered in the luteal phase exerts a marked and dose-dependent effect in premenstrual dysphoric disorder

21 January 2018

1 reference

Analysis of health-related quality of life and costs based on a randomised clinical trial of escitalopram for relapse prevention in patients with generalised social anxiety disorder

21 January 2018

1 reference

High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trial

21 January 2018

1 reference

Escitalopram: an open-label study of bereavement-related depression and grief

21 January 2018

1 reference

An open-label trial of escitalopram in children and adolescents with social anxiety disorder

21 January 2018

1 reference

Superiority of escitalopram to paroxetine in the treatment of depression

21 January 2018

1 reference

No effect of six weeks of treatment with escitalopram on mood in healthy volunteers--irrespective of genotype for the promoter of the serotonin transporter

21 January 2018

1 reference

The selective serotonin re-uptake inhibitor escitalopram modulates the panic response to cholecystokinin tetrapeptide in healthy men depending on 5-HTTLPR genotype

21 January 2018

1 reference

Escitalopram for older adults with generalized anxiety disorder: a randomized controlled trial

21 January 2018

1 reference

An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder

21 January 2018

1 reference

Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine

21 January 2018

1 reference

Escitalopram in the treatment of multisomatoform disorder: a double-blind, placebo-controlled trial

21 January 2018

1 reference

Escitalopram in painful polyneuropathy: a randomized, placebo-controlled, cross-over trial

21 January 2018

1 reference

High-dose escitalopram for the treatment of obsessive-compulsive disorder.

21 January 2018

1 reference

Escitalopram and problem-solving therapy for prevention of poststroke depression: a randomized controlled trial

21 January 2018

1 reference

An open randomized study of the treatment of escitalopram alone and combined with gamma-hydroxybutyric acid and naltrexone in alcoholic patients

21 January 2018

1 reference

Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression

21 January 2018

1 reference

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients

21 January 2018

1 reference

21 January 2018

1 reference

Escitalopram effects on insula and amygdala BOLD activation during emotional processing

21 January 2018

1 reference

Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder

21 January 2018

1 reference

Changes in sexual functioning associated with duloxetine, escitalopram, and placebo in the treatment of patients with major depressive disorder

21 January 2018

1 reference

Escitalopram prevents relapse in older patients with major depressive disorder

21 January 2018

1 reference

Open-label escitalopram treatment for pathological skin picking.

21 January 2018

1 reference

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

21 January 2018

1 reference

Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder

21 January 2018

1 reference

Safety and efficacy of escitalopram in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study.

21 January 2018

1 reference

Antidepressive therapy with escitalopram improves mood, cognitive symptoms, and identity memory for angry faces in elderly depressed patients.

21 January 2018

1 reference

Complicated grief: a case series using escitalopram

21 January 2018

1 reference

Escitalopram treatment of trichotillomania.

21 January 2018

1 reference

Escitalopram in the long-term treatment of major depressive disorder in elderly patients

21 January 2018

1 reference

Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study.

21 January 2018

1 reference

Escitalopram for compulsive buying disorder: a double-blind discontinuation study

21 January 2018

1 reference

The influence of educational information on depressed outpatients treated with escitalopram: a semi-naturalistic study

21 January 2018

1 reference

Escitalopram in major depressive disorder: a multicenter, randomized, double-blind, fixed-dose, parallel trial in a Chinese population.

21 January 2018

1 reference

Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial.

21 January 2018

1 reference

Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority study.

21 January 2018

1 reference

Predicting 6-week treatment response to escitalopram pharmacotherapy in late-life major depressive disorder

21 January 2018

1 reference

Safety and efficacy of oral escitalopram as continuation treatment of intravenous citalopram in patients with major depressive disorder.

21 January 2018

1 reference

Escitalopram versus sertraline in the treatment of major depressive disorder: a randomized clinical trial

21 January 2018

1 reference

A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorder

21 January 2018

1 reference

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

21 January 2018

1 reference

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies

21 January 2018

1 reference

Escitalopram for perimenopausal depression: an open-label pilot study.

21 January 2018

1 reference

In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram.

21 January 2018

1 reference

An open-label study of escitalopram in body dysmorphic disorder

21 January 2018

1 reference

An open-label study of escitalopram (Lexapro) for the treatment of 'Depression of Alzheimer's disease' (dAD).

21 January 2018

1 reference

Escitalopram versus ethinyl estradiol and norethindrone acetate for symptomatic peri- and postmenopausal women: impact on depression, vasomotor symptoms, sleep, and quality of life.

21 January 2018

1 reference

Escitalopram in the long-term treatment of major depressive disorder.

21 January 2018

1 reference

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

21 January 2018

1 reference

Mood and neuropsychological changes in women with midlife depression treated with escitalopram

21 January 2018

1 reference

A double-blind comparison of escitalopram and paroxetine in the long-term treatment of generalized anxiety disorder

21 January 2018

1 reference

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder

21 January 2018

1 reference

Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder

21 January 2018

1 reference

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder

21 January 2018

1 reference

An open-label trial of escitalopram in pervasive developmental disorders

21 January 2018

1 reference

New possibilities of treatment for panic attacks in elderly patients: escitalopram versus citalopram.

21 January 2018

1 reference

Escitalopram in clinical practice: results of an open-label trial in a naturalistic setting

21 January 2018

1 reference

Escitalopram/reboxetine combination in depressed patients with substance use disorder

21 January 2018

1 reference

Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study

21 January 2018

1 reference

Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study

21 January 2018

1 reference

Efficacy and tolerability of escitalopram in 12- and 24-week treatment of social anxiety disorder: randomised, double-blind, placebo-controlled, fixed-dose study

21 January 2018

1 reference

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder

21 January 2018

1 reference

Improved potency of escitalopram on the human serotonin transporter: demonstration of an ex vivo assay technique

21 January 2018

1 reference

Escitalopram 10 mg/day is effective and well tolerated in a placebo-controlled study in depression in primary care

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications

21 January 2018

1 reference

Effects of low to moderate acute doses of pramipexole on impulsivity and cognition in healthy volunteers

21 January 2018

1 reference

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

21 January 2018

1 reference

Effect of pramipexole on RLS symptoms and sleep: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

Dopamine and cognitive functioning in de novo subjects with Parkinson's disease: effects of pramipexole and pergolide on working memory.

21 January 2018

1 reference

Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence

21 January 2018

1 reference

Pramipexole in treatment-resistant depression: an extended follow-up

21 January 2018

1 reference

Pramipexole in comparison to l-dopa: a neuropsychological study

21 January 2018

1 reference

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

21 January 2018

1 reference

Efficacy, safety, and tolerability of pramipexole in untreated and levodopa-treated patients with Parkinson's disease

21 January 2018

1 reference

Efficacy and safety of pramipexole in restless legs syndrome.

21 January 2018

1 reference

Controlled withdrawal of pramipexole after 6 months of open-label treatment in patients with restless legs syndrome.

21 January 2018

1 reference

Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment

21 January 2018

1 reference

Low-dose pramipexole in the management of restless legs syndrome. An open label trial

21 January 2018

1 reference

Comparison of pramipexole and modafinil on arousal, autonomic, and endocrine functions in healthy volunteers

21 January 2018

1 reference

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

21 January 2018

1 reference

Pramipexole in Parkinson disease. Results of a treatment observation

21 January 2018

1 reference

A pilot double-blind placebo-controlled trial of low-dose pramipexole in sleep-related eating disorder

21 January 2018

1 reference

Pramipexole in patients with Parkinson's disease and marked drug resistant tremor: a randomised, double blind, placebo controlled multicentre study

21 January 2018

1 reference

Efficacy, safety, and tolerance of the non-ergoline dopamine agonist pramipexole in the treatment of advanced Parkinson's disease: a double blind, placebo controlled, randomised, multicentre study.

21 January 2018

1 reference

Reduction of oxidative stress in amyotrophic lateral sclerosis following pramipexole treatment

21 January 2018

1 reference

Efficacy and safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose-finding study--the PRELUDE study.

21 January 2018

1 reference

Pramipexole in levodopa-treated Parkinson disease patients of African, Asian, and Hispanic heritage

21 January 2018

1 reference

Dopamine transporter brain imaging to assess the effects of pramipexole vs levodopa on Parkinson disease progression

21 January 2018

1 reference

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

21 January 2018

1 reference

Pramipexole versus levodopa in patients with early Parkinson's disease: effect on generic and disease-specific quality of life

21 January 2018

1 reference

A randomly assigned double-blind cross-over study examining the relative anti-parkinsonian tremor effects of pramipexole and pergolide

21 January 2018

1 reference

Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease

21 January 2018

1 reference

Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on Parkinsonian tremor

21 January 2018

1 reference

Long-term efficacy and safety of pramipexole in advanced Parkinson's disease: results from a European multicenter trial

21 January 2018

1 reference

Randomized, double‐blind study of pramipexole with placebo and bromocriptine in advanced Parkinson's disease

21 January 2018

1 reference

The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.

21 January 2018

1 reference

First night efficacy of pramipexole in restless legs syndrome and periodic leg movements

21 January 2018

1 reference

Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease

21 January 2018

1 reference

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole

21 January 2018

1 reference

Pramipexole in treatment-resistant depression: a 16-week naturalistic study

21 January 2018

1 reference

Increase in body weight after pramipexole treatment in Parkinson's disease

21 January 2018

1 reference

Go-no-go task performance improvement after anodal transcranial DC stimulation of the left dorsolateral prefrontal cortex in major depression.

21 January 2018

1 reference

A randomized, double-blind clinical trial on the efficacy of cortical direct current stimulation for the treatment of major depression

21 January 2018

1 reference

Differential modulatory effects of transcranial direct current stimulation on a facial expression go-no-go task in males and females.

21 January 2018

1 reference

Prefrontal cortex modulation using transcranial DC stimulation reduces alcohol craving: a double-blind, sham-controlled study.

21 January 2018

1 reference

Modulatory effects of anodal transcranial direct current stimulation on perception and pain thresholds in healthy volunteers

21 January 2018

1 reference

Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making.

21 January 2018

1 reference

Noninvasive brain stimulation improves language learning.

21 January 2018

1 reference

A sham-controlled, phase II trial of transcranial direct current stimulation for the treatment of central pain in traumatic spinal cord injury.

21 January 2018

1 reference

Transcranial direct current stimulation of the unaffected hemisphere in stroke patients.

21 January 2018

1 reference

Treatment of major depression with transcranial direct current stimulation

21 January 2018

1 reference

Cognitive effects of repeated sessions of transcranial direct current stimulation in patients with depression

21 January 2018

1 reference

A randomized, sham-controlled, proof of principle study of transcranial direct current stimulation for the treatment of pain in fibromyalgia

21 January 2018

1 reference

Transient tinnitus suppression induced by repetitive transcranial magnetic stimulation and transcranial direct current stimulation.

21 January 2018

1 reference

Transcranial direct current stimulation of the prefrontal cortex modulates the desire for specific foods

21 January 2018

1 reference

Transcranial DC stimulation (tDCS): a tool for double-blind sham-controlled clinical studies in brain stimulation.

21 January 2018

1 reference

Enhancing the working memory of stroke patients using tDCS.

21 January 2018

1 reference

Facilitation of probabilistic classification learning by transcranial direct current stimulation of the prefrontal cortex in the human.

21 January 2018

1 reference

Studying the neurobiology of social interaction with transcranial direct current stimulation--the example of punishing unfairness.

21 January 2018

1 reference

Improvement of visual scanning after DC brain polarization of parietal cortex in stroke patients with spatial neglect.

21 January 2018

1 reference

Bilateral frontal transcranial direct current stimulation: Failure to replicate classic findings in healthy subjects

21 January 2018

1 reference

Transcranial direct current stimulation during sleep improves declarative memory.

21 January 2018

1 reference

Time-dependent effect of transcranial direct current stimulation on the enhancement of working memory.

21 January 2018

1 reference

Myoinositol content in the human brain is modified by transcranial direct current stimulation in a matter of minutes: a 1H-MRS study.

21 January 2018

1 reference

Site-specific effects of transcranial direct current stimulation on sleep and pain in fibromyalgia: a randomized, sham-controlled study.

21 January 2018

1 reference

Pergolide increases the efficacy of cathodal direct current stimulation to reduce the amplitude of laser-evoked potentials in humans

21 January 2018

1 reference

Contralateral and ipsilateral motor effects after transcranial direct current stimulation.

21 January 2018

1 reference

Right prefrontal repetitive transcranial magnetic stimulation in obsessive-compulsive disorder: a double-blind, placebo-controlled study.

21 January 2018

1 reference

Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption

21 January 2018

1 reference

Transcranial magnetic stimulation for pain control. Double-blind study of different frequencies against placebo, and correlation with motor cortex stimulation efficacy.

21 January 2018

1 reference

A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression

21 January 2018

1 reference

Lack of impact of repetitive High Frequency Transcranial Magnetic Stimulation on mood in healthy female subjects.

21 January 2018

1 reference

Effect of augmentatory repetitive transcranial magnetic stimulation on auditory hallucinations in schizophrenia: randomized controlled study

21 January 2018

1 reference

A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression.

21 January 2018

1 reference

Postoperative left prefrontal repetitive transcranial magnetic stimulation reduces patient-controlled analgesia use.

21 January 2018

1 reference

Lack of a therapeutic effect of a 2-week sub-threshold transcranial magnetic stimulation course for treatment-resistant depression.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson's disease.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation (rTMS) in combination with escitalopram in patients with treatment-resistant major depression: a double-blind, randomised, sham-controlled trial

21 January 2018

1 reference

Improvement of choreic movements by 1 Hz repetitive transcranial magnetic stimulation in Huntington's disease patients

21 January 2018

1 reference

One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving.

21 January 2018

1 reference

SPECT mapping of cerebral activity changes induced by repetitive transcranial magnetic stimulation in depressed patients. A pilot study

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of the motor cortex ameliorates spasticity in multiple sclerosis.

21 January 2018

1 reference

Effect of electroconvulsive therapy on cortical excitability in patients with major depression: a transcranial magnetic stimulation study.

21 January 2018

1 reference

Transcranial magnetic stimulation for migraine: clinical effects

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in posttraumatic stress disorder: a double-blind, placebo-controlled study

21 January 2018

1 reference

Transcranial magnetic stimulation improves naming in Alzheimer disease patients at different stages of cognitive decline.

21 January 2018

1 reference

Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's disease.

21 January 2018

1 reference

Augmentative repetitive navigated transcranial magnetic stimulation (rTMS) in drug-resistant bipolar depression.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation for ALS. A preliminary controlled study.

21 January 2018

1 reference

Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study.

21 January 2018

1 reference

Sleep deprivation in depression stabilizing antidepressant effects by repetitive transcranial magnetic stimulation.

21 January 2018

1 reference

Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series

21 January 2018

1 reference

A randomized, controlled trial with 6-month follow-up of repetitive transcranial magnetic stimulation and electroconvulsive therapy for severe depression

21 January 2018

1 reference

Left prefrontal activation predicts therapeutic effects of repetitive transcranial magnetic stimulation (rTMS) in major depression.

21 January 2018

1 reference

Antidepressant efficacy and cognitive effects of repetitive transcranial magnetic stimulation in vascular depression: an open trial.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

A double-blind sham-controlled trial of repetitive transcranial magnetic stimulation in the treatment of refractory auditory hallucinations.

21 January 2018

1 reference

A comparative study of the effects of repetitive paired transcranial magnetic stimulation on motor cortical excitability.

21 January 2018

1 reference

A randomized trial of the anti-depressant effects of low- and high-frequency transcranial magnetic stimulation in treatment-resistant depression.

21 January 2018

1 reference

Effects of repetitive transcranial magnetic stimulation (rTMS) on chronic tinnitus.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease.

21 January 2018

1 reference

Clinical application of single-pulse transcranial magnetic stimulation for the treatment of depression

21 January 2018

1 reference

Modest adjunctive benefit with transcranial magnetic stimulation in medication-resistant depression.

21 January 2018

1 reference

Prefrontal repetitive transcranial magnetic stimulation as add on treatment in depression

21 January 2018

1 reference

Transcranial magnetic stimulation of the cerebellum in essential tremor: a controlled study.

21 January 2018

1 reference

Diffusion tensor fiber tracking in patients with central post-stroke pain; correlation with efficacy of repetitive transcranial magnetic stimulation

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of dorsolateral prefrontal cortex increases tolerance to human experimental pain.

21 January 2018

1 reference

Effect of transcranial magnetic stimulation in posttraumatic stress disorder: a preliminary study.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation is as effective as electroconvulsive therapy in the treatment of nondelusional major depressive disorder: an open study.

21 January 2018

1 reference

A randomized controlled comparison of electroconvulsive therapy and repetitive transcranial magnetic stimulation in severe and resistant nonpsychotic major depression

21 January 2018

1 reference

Transcranial magnetic stimulation: no effect on mood with single pulse during learned helplessness.

21 January 2018

1 reference

High-frequency repetitive transcranial magnetic stimulation in schizophrenia: a combined treatment and neuroimaging study.

21 January 2018

1 reference

Reduction of intractable deafferentation pain by navigation-guided repetitive transcranial magnetic stimulation of the primary motor cortex.

21 January 2018

1 reference

Transcranial magnetic stimulation of left temporoparietal cortex in three patients reporting hallucinated "voices".

21 January 2018

1 reference

Temporoparietal transcranial magnetic stimulation for auditory hallucinations: safety, efficacy and moderators in a fifty patient sample.

21 January 2018

1 reference

Transcranial magnetic stimulation of left temporoparietal cortex and medication-resistant auditory hallucinations.

21 January 2018

1 reference

Shorter duration of depressive episode may predict response to repetitive transcranial magnetic stimulation

21 January 2018

1 reference

Gender differences in the effect of repetitive transcranial magnetic stimulation in schizophrenia

21 January 2018

1 reference

Influence of repetitive transcranial magnetic stimulation on disease severity and oxidative stress markers in the cerebrospinal fluid of patients with spinocerebellar degeneration

21 January 2018

1 reference

Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson's disease.

21 January 2018

1 reference

[Central and peripheral deafferent pain: therapy with repetitive transcranial magnetic stimulation].

21 January 2018

1 reference

Ultrahigh frequency repetitive transcranial magnetic stimulation in unipolar depression.

21 January 2018

1 reference

Treating auditory hallucinations by transcranial magnetic stimulation: a randomized controlled cross-over trial.

21 January 2018

1 reference

A double-blind sham controlled study of right prefrontal repetitive transcranial magnetic stimulation (rTMS): therapeutic and cognitive effect in medication free unipolar depression during 4 weeks

21 January 2018

1 reference

Antiepileptic effects of low-frequency repetitive transcranial magnetic stimulation by different stimulation durations and locations.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation as treatment of poststroke depression: a preliminary study.

21 January 2018

1 reference

Slow right prefrontal transcranial magnetic stimulation as a treatment for medication-resistant depression: a double-blind, placebo-controlled study

21 January 2018

1 reference

Treatment of post-stroke dysphagia with repetitive transcranial magnetic stimulation

21 January 2018

1 reference

Effect of daily repetitive transcranial magnetic stimulation for treatment of tinnitus: comparison of different stimulus frequencies.

21 January 2018

1 reference

Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: preliminary results.

21 January 2018

1 reference

Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's disease

21 January 2018

1 reference

Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET study

21 January 2018

1 reference

Regional cerebral blood flow changes after low-frequency transcranial magnetic stimulation of the right dorsolateral prefrontal cortex in treatment-resistant depression

21 January 2018

1 reference

Therapeutic efficacy of right prefrontal slow repetitive transcranial magnetic stimulation in major depression: a double-blind controlled study.

21 January 2018

1 reference

Long-term effects of repetitive transcranial magnetic stimulation (rTMS) in patients with chronic tinnitus.

21 January 2018

1 reference

[Treatment of chronic tinnitus with neuronavigated repetitive Transcranial Magnetic Stimulation (rTMS)].

21 January 2018

1 reference

Low frequency repetitive transcranial magnetic stimulation (rTMS) for the treatment of chronic tinnitus--are there long-term effects?

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation in veterans with debilitating tinnitus: a pilot study

21 January 2018

1 reference

Pain relief induced by repetitive transcranial magnetic stimulation of precentral cortex

21 January 2018

1 reference

Neurogenic pain relief by repetitive transcranial magnetic cortical stimulation depends on the origin and the site of pain

21 January 2018

1 reference

Interventional neurophysiology for pain control: duration of pain relief following repetitive transcranial magnetic stimulation of the motor cortex

21 January 2018

1 reference

A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation

21 January 2018

1 reference

Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial

21 January 2018

1 reference

Effects of repetitive transcranial magnetic stimulation in depression: a magnetoencephalographic study.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation as an adjunct to constraint-induced therapy: an exploratory randomized controlled trial

21 January 2018

1 reference

Recovery of motor disability and spasticity in post-stroke after repetitive transcranial magnetic stimulation (rTMS).

21 January 2018

1 reference

Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulation.

21 January 2018

1 reference

Repetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of panic disorder (PD) with comorbid major depression

21 January 2018

1 reference

Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression.

21 January 2018

1 reference

Transcranial magnetic stimulation for auditory hallucinations in schizophrenia

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation (rTMS) at high and low frequency: an efficacious therapy for major drug-resistant depression?

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation for negative symptoms of schizophrenia: a randomized controlled pilot study.

21 January 2018

1 reference

The effects of repetitive transcranial magnetic stimulation on depressive symptoms and the P(300) event-related potential.

21 January 2018

1 reference

Mood effects of repetitive transcranial magnetic stimulation of left prefrontal cortex in healthy volunteers

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation: a putative add-on treatment for major depression in elderly patients.

21 January 2018

1 reference

Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: a pilot study of acute safety and efficacy

21 January 2018

1 reference

Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?

21 January 2018

1 reference

Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial

21 January 2018

1 reference

0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's disease.

21 January 2018

1 reference

Relation between responses to repetitive transcranial magnetic stimulation and partial sleep deprivation in major depression

21 January 2018

1 reference

Plasma concentrations of neuroactive steroids before and after repetitive transcranial magnetic stimulation (rTMS) in major depression

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.

21 January 2018

1 reference

Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drug-resistant depression.

21 January 2018

1 reference

Effects of unilateral repetitive transcranial magnetic stimulation of the motor cortex on chronic widespread pain in fibromyalgia

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of the motor cortex attenuates pain perception in complex regional pain syndrome type I.

21 January 2018

1 reference

Moderate therapeutic efficacy of positron emission tomography-navigated repetitive transcranial magnetic stimulation for chronic tinnitus: a randomised, controlled pilot study.

21 January 2018

1 reference

Transcranial magnetic stimulation and muscle contraction to enhance stroke recovery: a randomized proof-of-principle and feasibility investigation

21 January 2018

1 reference

Slow transcranial magnetic stimulation can rapidly reduce resistant auditory hallucinations in schizophrenia.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation does not potentiate antidepressant treatment

21 January 2018

1 reference

Transcranial magnetic stimulation in the treatment of psychiatric disorders

21 January 2018

1 reference

Treatment of negative symptoms of schizophrenia using repetitive transcranial magnetic stimulation in a double-blind, randomized controlled study

21 January 2018

1 reference

Cognitive functioning after repetitive transcranial magnetic stimulation in patients with cerebrovascular disease without dementia: a pilot study of seven patients.

21 January 2018

1 reference

High frequency repetitive transcranial magnetic stimulation (rTMS) of the dorsolateral prefrontal cortex in schizophrenic patients.

21 January 2018

1 reference

Comparison of repetitive transcranial magnetic stimulation and electroconvulsive therapy in unipolar non-psychotic refractory depression: a randomized, single-blind study

21 January 2018

1 reference

Effects of repetitive transcranial magnetic stimulation on chronic tinnitus: a randomised, crossover, double blind, placebo controlled study

21 January 2018

1 reference

Transcranial magnetic stimulation in treatment-resistant depressed patients: a double-blind, placebo-controlled trial.

21 January 2018

1 reference

Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study

21 January 2018

1 reference

Transcranial magnetic stimulation in the treatment of schizophrenic symptoms: a double blind sham controlled study.

21 January 2018

1 reference

Slow frequency repetitive transcranial magnetic stimulation affects reaction times, but not priming effects, in a masked prime task.

21 January 2018

1 reference

Effects of antidepressant pharmacotherapy after repetitive transcranial magnetic stimulation in major depression: an open follow-up study

21 January 2018

1 reference

Transcranial magnetic stimulation alleviates truncal ataxia in spinocerebellar degeneration

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's disease

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation for tinnitus: a pilot study.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation effects on brain function and cognition among elders with memory dysfunction. A randomized sham-controlled study.

21 January 2018

1 reference

Lack of adverse cognitive effects of 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression.

21 January 2018

1 reference

Therapeutic application of transcranial magnetic stimulation in Parkinson's disease: the contribution of expectation

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation of contralesional primary motor cortex improves hand function after stroke.

21 January 2018

1 reference

Effects of 1-Hz repetitive transcranial magnetic stimulation on acute pain induced by capsaicin

21 January 2018

1 reference

Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold

21 January 2018

1 reference

Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving.

21 January 2018

1 reference

Effect of transcranial magnetic stimulation on voluntary activation in patients with quadriceps weakness

21 January 2018

1 reference

Beneficial effect of transcranial magnetic stimulation on sleep in Parkinson's disease.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, sham-controlled trial in female outpatients.

21 January 2018

1 reference

Safety and behavioral effects of high-frequency repetitive transcranial magnetic stimulation in stroke

21 January 2018

1 reference

The combined dexamethasone-CRH test before and after repetitive transcranial magnetic stimulation (rTMS) in major depression

21 January 2018

1 reference

Changes in human EEG alpha activity following exposure to two different pulsed magnetic field sequences.

21 January 2018

1 reference

Effects of picotesla flux electromagnetic fields on dopaminergic transmission in Tourette's syndrome

21 January 2018

1 reference

Transcranial magnetic stimulation and the human brain

21 January 2018

1 reference

Clinical impacts of single transcranial magnetic stimulation (sTMS) as an add-on therapy in severely depressed patients under SSRI treatment.

21 January 2018

1 reference

Transcranial magnetic stimulation-induced switch into mania: a report of two cases.

21 January 2018

1 reference

Occurrence of delusions during repetitive transcranial magnetic stimulation (rTMS) in major depression

21 January 2018

1 reference

Metabolic alterations in the dorsolateral prefrontal cortex after treatment with high-frequency repetitive transcranial magnetic stimulation in patients with unipolar major depression.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation activates specific regions in rat brain.

21 January 2018

1 reference

Theta burst stimulation of the human motor cortex

21 January 2018

1 reference

Pharmacological modulation of cortical excitability shifts induced by transcranial direct current stimulation in humans

21 January 2018

1 reference

MRI study of human brain exposed to weak direct current stimulation of the frontal cortex

21 January 2018

1 reference

Safety limits of cathodal transcranial direct current stimulation in rats

21 January 2018

1 reference

Patterns of response to repetitive transcranial magnetic stimulation (rTMS) in major depression: replication study in drug-free patients

21 January 2018

1 reference

Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation

21 January 2018

1 reference

Pharmacological approach to the mechanisms of transcranial DC-stimulation-induced after-effects of human motor cortex excitability

21 January 2018

1 reference

Non-synaptic mechanisms underlie the after-effects of cathodal transcutaneous direct current stimulation of the human brain.

21 January 2018

1 reference

Capturing user requirements in medical device development: the role of ergonomics.

21 January 2018

1 reference

Medical device development: from prototype to regulatory approval

21 January 2018

1 reference

Placebo response of non-pharmacological and pharmacological trials in major depression: a systematic review and meta-analysis

21 January 2018

1 reference

Treatment with electromagnetic fields reverses the long-term clinical course of a patient with chronic progressive multiple sclerosis

21 January 2018

1 reference

Controlling conflict of interest--proposals from the Institute of Medicine.

21 January 2018

1 reference

The Effect of Focused Ultrasound on the Skin and Deep Nerve Structures of Man and Animal

21 January 2018

1 reference

Prevention of relapse in generalized anxiety disorder by escitalopram treatment

21 January 2018

1 reference

Antidepressant effects of different schedules of repetitive transcranial magnetic stimulation vs. clomipramine in patients with major depression: relationship to changes in cortical excitability

21 January 2018

1 reference

A randomized trial of low-frequency right-prefrontal-cortex transcranial magnetic stimulation as augmentation in treatment-resistant major depression.

21 January 2018

1 reference

Repetitive transcranial magnetic stimulation (rTMS) in the treatment of obsessive-compulsive disorder (OCD) and Tourette's syndrome (TS).

21 January 2018

1 reference

Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

21 January 2018

1 reference

Escitalopram prevents relapse of obsessive-compulsive disorder

21 January 2018

1 reference

Escitalopram in obsessive–compulsive disorder: a randomized, placebo-controlled, paroxetine-referenced, fixed-dose, 24-week study

21 January 2018

1 reference

Enhancing language performance with non-invasive brain stimulation—A transcranial direct current stimulation study in healthy humans

21 January 2018

1 reference

A Pilot Safety Study of Repetitive Transcranial Magnetic Stimulation (rTMS) in Tourette’s Syndrome

21 January 2018

1 reference

Transcranial magnetic stimulation for the deficit syndrome of schizophrenia: A pilot investigation

21 January 2018

1 reference

Escitalopram in Seasonal Affective Disorder: Results of an Open Trial

21 January 2018

1 reference

Escitalopram in a working population: results from an observational study of 2378 outpatients in Austria

21 January 2018

1 reference

Pramipexole as adjunct to haloperidol in schizophrenia

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERD.09.64

1 reference

27 July 2017

1 reference

PubMed ID

20021241